Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the acquisition of Microbia, Inc. (Lexington, Massachusetts, United States) from Ironwood Pharmaceuticals, Inc. The terms of the acquisition will not be disclosed.
Microbia is a successful industrial biotechnology research and development specialist. It has developed a highly effective technology platform that enables it to produce high-quality, natural carotenoids (including ?-carotene and canthaxanthin), nutritional products and other specialty materials and chemicals from renewable resources.
Microbia's sales are still limited. The acquisition will allow DSM to incorporate Microbia's proprietary platform and world class research and development capabilities and support DSM's ongoing development of the natural carotenoids market.
Leendert Staal, President and CEO of DSM Nutritional Products commented: "The acquisition of Microbia represents a significant step for DSM in our strategy to accelerate our innovation activities in natural products and fermentation processes. This acquisition allows us to expand our product portfolio as well as our research and development capabilities."
Kevin Madden, Chief Science Officer of Microbia added, "We are thrilled to join DSM. Being part of a large global organization, and a world leader in industrial biotechnology, vitamins and carotenoid development, manufacturing and sales will expedite our ability to leverage our proprietary bio-based technology platform. We look forward to help accelerate DSM's ongoing efforts to develop, produce and commercialize the next generation of nutritional ingredients and other materials that will help the food, feed, chemicals and other industries produce more innovative and sustainable products, in a far more cost effective and responsible manner."
About Microbia
Microbia, Inc. (formerly Microbia Precision Engineering) is an industrial biotechnology company applying proprietary metabolic engineering utilizing fermentation technology to create natural, cost-effective, renewable specialty ingredients and biomaterials.
About DSM Nutritional Products
DSM Nutritional Products is the world's leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries. The business has sales of over EUR 2 billion and a long tradition as a pioneer in the discovery of new products, new formulations and attractive applications for all industry segments. For further company information please visit www.dsmnutritionalproducts.com (http://www.dsmnutritionalproducts.com)
DSM - the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about EUR8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, withlocations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com (http://www.dsm.com)
For more information: DSM Corporate Communications DSM Investor Relations Herman Betten Hans Vossen tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864 fax +31 (0) 45 5740680 fax +31 (0) 10 4590275 e-mail [email protected] (mailto:[email protected]) e-mail [email protected] (mailto:[email protected])
HUG?1445921
Press release-pdf: http://hugin.info/130663/R/1445921/389029.pdf (http://hugin.info/130663/R/1445921/389029.pdf)
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
